Products
NeuroQuantix Platform | Cerebral Innovations
Product description
NeuroQuantix is a digitized spiral drawing assessment platform designed for clinical trial regulatory submission. It provides objective, quantitative motor endpoints across 23 neurological conditions, compliant with 21 CFR Part 11, EU GMP Annex 11, and GxP standards. The platform utilizes a deep kinematic library and iPad-based assessment for minimal site burden.